CERo Therapeutics Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
CERo Therapeutics is continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA
- Go to the previous page
- 1
- …
- 339
- 340
- 341
- 342
- 343
- 344
- 345
- …
- 738
- Go to the next page